Cardiac Diseases During Systemic Inflammatory Diseases in the Internal Medicine and Medical Oncology Department of NTHC-HKM of Cotonou

Azon Kouanou Angèle; Wanvoegbè Finagnon Armand; Agbodandé Kouessi Anthelme; Saïzonou Franck; Ahmed Adama; Alassani Adébayo; Dovonou Comlan Albert; Zannou Djimon Marcel; Houngbé Fabien

doi:doi:10.11648/j.ajim.20210906.13

Cardiac Diseases During Systemic Inflammatory Diseases in the Internal Medicine and Medical Oncology Department of NTHC-HKM of Cotonou

Azon Kouanou Angèle, Wanvoegbè Finagnon Armand, Agbodandé Kouessi Anthelme, Saïzonou Franck, Ahmed Adama, Alassani Adébayo, Dovonou Comlan Albert, Zannou Djimon Marcel, Houngbé Fabien

Published in American Journal of Internal Medicine (Volume 9, Issue 6)

Received: 29 October 2021 Accepted: 16 November 2021 Published: 25 November 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Systemic inflammatory diseases are characterized by multivisceral involvement at some point in their evolution. This involvement can concern almost all organs, including the heart. Each systemic condition has a unique cardiac expression. The target of this study is to determine the frequency of cardiac involvement in systemic inflammatory diseases. This study is a cross-sectional, descriptive, and analytical study that was conducted within 07 months. The aim was to screen 23 patients followed for systemic inflammatory diseases for cardiac involvement. The mean age was 44 (±12) years old with a minimum of 24 and a maximum 64 years. Most of patients were women with a sex ratio (M/F) of 0.09. An echocardiographic abnormality was found in 26.1% of patients and 73.1% had an ECG abnormality. They included left atrial hypertrophy (43.4%), left ventricular hypertrophy (30.4%), right axial deviation (26.1%), low voltage (21.7%), right atrial hypertrophy (8.6%), S1Q3 appearance (8, 6%), pulmonary hypertension (8.6%), repolarization disorders (8.6%), sinus tachycardia (8.6%), middle tricuspid insufficiency (4.3%), middle pulmonary insufficiency (4.3%), and pericarditis (4.3%). Patients with systemic inflammatory diseases had cardiac disorders with rare clinical manifestations but with an incidental discovery either on ECG or on cardiac echodoppler. Hence, a systematic cardiac exploration in these patients was essential.

Published in	American Journal of Internal Medicine (Volume 9, Issue 6)
DOI	10.11648/j.ajim.20210906.13
Page(s)	257-261
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

Systemic Inflammatory Disease, Heart Disease, Cotonou

References

[1]	Chapelon AC. Manifestations cardiaques des maladies auto-immunes et vascularites. EMC–Cardiologie. 2016; 11 (2): 1-12.
[2]	Guillevin L. Myocardites des maladies systémiques. Arch Mal Coeur Vaiss. Prat 2017; 2017: 7–11. DOI: 10.1016/j.amcp.2017.10.003.
[3]	Ghriss N, Sayhi S, Dhahri D, Guediche NH, Boussetta H, Ben Abdelhafidh H, Ajili F, Louzir B. Atteinte cardiaque au cours du lupus érythémateux systémique. La Revue de médecine interne. 2019; 40: A101-20.
[4]	Launay D, De Groote P, Gaxotte V, Charlanne H, Beregi J-P, Hatron P-Y, Hachulla E. Atteinte cardiaque de la sclérodermie systémique. John Libbey Eurotext. 2006. 2 (3): 339-54.
[5]	Belhassen A, Toujani S, El Ouni A, Meddeb Z, Abdelkefi Z, Larbi T, Hamzaoui S, Bouslama K. Caractéristiques de l’atteinte cardiaque au cours de la granulomatose éosinophilique avec polyangéite. Annales de Cardiologie et d’Angéiologie. 2021; 1421: 1-4.
[6]	Azon-Kouanou A, Aboué NCA, Missiho MSG, Dansou E, Sokadjo YM, Agbodande KA and al. Knowledge of General Practitioners in Cotonou about Systemic Lupus Erythematosus. Open Journal of Internal Medicine. 2020; 10: 311-20. DOI: 10.4236/ojim.2020.104032.
[7]	Kane BS, Niasse M, Ndiaye AA, Ndao AC, Djiba B, Diack ND and al. Systemic Diseases in Dakar (Senegal): Spectrum, Epidemiological Aspect and Diagnostic Time-Limit. Open Journal of Internal Medicine. 2018; 8: 196-206. DOI: 10.4236/ojim.2018.83019.
[8]	Ngaïde AA, Ly F, Ly K, Diao M, Kane Ad, Mbaye A et al. Les manifestations cardio-vasculaires au cours du lupus érythémateux systémiques à Dakar. Etude descriptive à propos de 50 cas. Bull. Soc. Pathol. Exot. 2006; 109 (5): 345-52.
[9]	Tazi-Mezalek Z, Harmouch H, Adnoui M, et al. Particularités du lupus érythémateux disséminé au Maroc. A propos de 166 observations. Rev Méd Interne. 2000; 21 (S4): 465-6.
[10]	Agbodande KA, Prudencio RDT, Azon-Kouanou A, Wanvoegbe A, Cossou-Gbeto C, Zannou DM, et al. Panorama des connectivites en Médecine Interne au Centre National Hospitalier et Universitaire-Hubert Koutoukou Maga de Cotonou. Journal de la Société de Biologie Clinique du Bénin.2019; 031: 66-70.
[11]	Kakpovi K, Koffi-Tessio V, Houzou P, Fianyo E, Kolou M, Kuéviakoé MI et al. Profil de la polyarthrite rhumatoïde en consultation rhumatologique à Lomé (Togo). European Scientific Journal. 2017; 13 (15): 1857-7881.
[12]	Paule P, Braem L, Heno P, Miltgen J, Verrot D, Fourcade L and al. Diagnosis of cardiac sarcoidosis and follow-up of 24 consecutive patients. La revue de médecine interne. 2004; 25: 357-62.
[13]	Nunes H. Pneumopathies interstitielles diffuses au cours de la sarcoïdose. Revue des maladies respiratoires. 2005; 22 (5): 106-11.
[14]	Koh ET, Gladman DD, Abu-Sakra M. Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients. Br J Rheumatol. 1996; 35: 989-93.
[15]	Battle RW, Davitt MA, Cooper SM, Buckley LM, Leib ES, Beglin PA and al. Prevalence of pulmonary hypertension in limited and diffuse scleroderma. Chest. 1996; 110: 1515-9.
[16]	B’Niyatna: Complications cardiovasculaires au cours de la Polyarthrite Rhumatoïde au Centre National Hospitalier et Universitaire Hubert Koutoukou Maga de Cotonou (Bénin). [Mémoire de Spécialité en Cardiologie]. Cotonou: Université d’Abomey-Calavi, Faculté de Sciences de la Santé. 2017.

Cite This Article

Plain Text BibTeX RIS

APA Style

Azon Kouanou Angèle, Wanvoegbè Finagnon Armand, Agbodandé Kouessi Anthelme, Saïzonou Franck, Ahmed Adama, et al. (2021). Cardiac Diseases During Systemic Inflammatory Diseases in the Internal Medicine and Medical Oncology Department of NTHC-HKM of Cotonou. American Journal of Internal Medicine, 9(6), 257-261. https://doi.org/10.11648/j.ajim.20210906.13

Copy | Download

ACS Style

Azon Kouanou Angèle; Wanvoegbè Finagnon Armand; Agbodandé Kouessi Anthelme; Saïzonou Franck; Ahmed Adama, et al. Cardiac Diseases During Systemic Inflammatory Diseases in the Internal Medicine and Medical Oncology Department of NTHC-HKM of Cotonou. Am. J. Intern. Med. 2021, 9(6), 257-261. doi: 10.11648/j.ajim.20210906.13

Copy | Download

AMA Style

Azon Kouanou Angèle, Wanvoegbè Finagnon Armand, Agbodandé Kouessi Anthelme, Saïzonou Franck, Ahmed Adama, et al. Cardiac Diseases During Systemic Inflammatory Diseases in the Internal Medicine and Medical Oncology Department of NTHC-HKM of Cotonou. Am J Intern Med. 2021;9(6):257-261. doi: 10.11648/j.ajim.20210906.13

Copy | Download

@article{10.11648/j.ajim.20210906.13,
  author = {Azon Kouanou Angèle and Wanvoegbè Finagnon Armand and Agbodandé Kouessi Anthelme and Saïzonou Franck and Ahmed Adama and Alassani Adébayo and Dovonou Comlan Albert and Zannou Djimon Marcel and Houngbé Fabien},
  title = {Cardiac Diseases During Systemic Inflammatory Diseases in the Internal Medicine and Medical Oncology Department of NTHC-HKM of Cotonou},
  journal = {American Journal of Internal Medicine},
  volume = {9},
  number = {6},
  pages = {257-261},
  doi = {10.11648/j.ajim.20210906.13},
  url = {https://doi.org/10.11648/j.ajim.20210906.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajim.20210906.13},
  abstract = {Systemic inflammatory diseases are characterized by multivisceral involvement at some point in their evolution. This involvement can concern almost all organs, including the heart. Each systemic condition has a unique cardiac expression. The target of this study is to determine the frequency of cardiac involvement in systemic inflammatory diseases. This study is a cross-sectional, descriptive, and analytical study that was conducted within 07 months. The aim was to screen 23 patients followed for systemic inflammatory diseases for cardiac involvement. The mean age was 44 (±12) years old with a minimum of 24 and a maximum 64 years. Most of patients were women with a sex ratio (M/F) of 0.09. An echocardiographic abnormality was found in 26.1% of patients and 73.1% had an ECG abnormality. They included left atrial hypertrophy (43.4%), left ventricular hypertrophy (30.4%), right axial deviation (26.1%), low voltage (21.7%), right atrial hypertrophy (8.6%), S1Q3 appearance (8, 6%), pulmonary hypertension (8.6%), repolarization disorders (8.6%), sinus tachycardia (8.6%), middle tricuspid insufficiency (4.3%), middle pulmonary insufficiency (4.3%), and pericarditis (4.3%). Patients with systemic inflammatory diseases had cardiac disorders with rare clinical manifestations but with an incidental discovery either on ECG or on cardiac echodoppler. Hence, a systematic cardiac exploration in these patients was essential.},
 year = {2021}
}

Copy | Download

TY - JOUR
T1 - Cardiac Diseases During Systemic Inflammatory Diseases in the Internal Medicine and Medical Oncology Department of NTHC-HKM of Cotonou
AU - Azon Kouanou Angèle
AU - Wanvoegbè Finagnon Armand
AU - Agbodandé Kouessi Anthelme
AU - Saïzonou Franck
AU - Ahmed Adama
AU - Alassani Adébayo
AU - Dovonou Comlan Albert
AU - Zannou Djimon Marcel
AU - Houngbé Fabien
Y1 - 2021/11/25
PY - 2021
N1 - https://doi.org/10.11648/j.ajim.20210906.13
DO - 10.11648/j.ajim.20210906.13
T2 - American Journal of Internal Medicine
JF - American Journal of Internal Medicine
JO - American Journal of Internal Medicine
SP - 257
EP - 261
PB - Science Publishing Group
SN - 2330-4324
UR - https://doi.org/10.11648/j.ajim.20210906.13
AB - Systemic inflammatory diseases are characterized by multivisceral involvement at some point in their evolution. This involvement can concern almost all organs, including the heart. Each systemic condition has a unique cardiac expression. The target of this study is to determine the frequency of cardiac involvement in systemic inflammatory diseases. This study is a cross-sectional, descriptive, and analytical study that was conducted within 07 months. The aim was to screen 23 patients followed for systemic inflammatory diseases for cardiac involvement. The mean age was 44 (±12) years old with a minimum of 24 and a maximum 64 years. Most of patients were women with a sex ratio (M/F) of 0.09. An echocardiographic abnormality was found in 26.1% of patients and 73.1% had an ECG abnormality. They included left atrial hypertrophy (43.4%), left ventricular hypertrophy (30.4%), right axial deviation (26.1%), low voltage (21.7%), right atrial hypertrophy (8.6%), S1Q3 appearance (8, 6%), pulmonary hypertension (8.6%), repolarization disorders (8.6%), sinus tachycardia (8.6%), middle tricuspid insufficiency (4.3%), middle pulmonary insufficiency (4.3%), and pericarditis (4.3%). Patients with systemic inflammatory diseases had cardiac disorders with rare clinical manifestations but with an incidental discovery either on ECG or on cardiac echodoppler. Hence, a systematic cardiac exploration in these patients was essential.
VL - 9
IS - 6
ER -

Copy | Download

Author Information

Azon Kouanou Angèle

Internal Medicine and Medical Oncology Department, National Teaching Hospital Center (NTHC)-Hubert Koutougou Maga (HKM), Cotonou, Republic of Benin
Wanvoegbè Finagnon Armand

Internal Medicine Department, Regional Hospital Teachiing Center of Oueme Plateau (RHTC-OP), Porto-Novo, Republic of Benin
Agbodandé Kouessi Anthelme

Internal Medicine and Medical Oncology Department, National Teaching Hospital Center (NTHC)-Hubert Koutougou Maga (HKM), Cotonou, Republic of Benin
Saïzonou Franck
Ahmed Adama

Internal Medicine and Medical Oncology Department, National Teaching Hospital Center (NTHC)-Hubert Koutougou Maga (HKM), Cotonou, Republic of Benin
Alassani Adébayo

Internal Medicine Department, Regional Hospital Teachiing Center of Borgou Atacora (RHTC-BA), Parakou, Republic of Benin
Dovonou Comlan Albert

Internal Medicine Department, Regional Hospital Teachiing Center of Borgou Atacora (RHTC-BA), Parakou, Republic of Benin
Zannou Djimon Marcel

Internal Medicine and Medical Oncology Department, National Teaching Hospital Center (NTHC)-Hubert Koutougou Maga (HKM), Cotonou, Republic of Benin
Houngbé Fabien

Internal Medicine and Medical Oncology Department, National Teaching Hospital Center (NTHC)-Hubert Koutougou Maga (HKM), Cotonou, Republic of Benin

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Azon Kouanou Angèle, Wanvoegbè Finagnon Armand, Agbodandé Kouessi Anthelme, Saïzonou Franck, Ahmed Adama, et al. (2021). Cardiac Diseases During Systemic Inflammatory Diseases in the Internal Medicine and Medical Oncology Department of NTHC-HKM of Cotonou. American Journal of Internal Medicine, 9(6), 257-261. https://doi.org/10.11648/j.ajim.20210906.13

Copy | Download

ACS Style

Azon Kouanou Angèle; Wanvoegbè Finagnon Armand; Agbodandé Kouessi Anthelme; Saïzonou Franck; Ahmed Adama, et al. Cardiac Diseases During Systemic Inflammatory Diseases in the Internal Medicine and Medical Oncology Department of NTHC-HKM of Cotonou. Am. J. Intern. Med. 2021, 9(6), 257-261. doi: 10.11648/j.ajim.20210906.13

Copy | Download

AMA Style

Azon Kouanou Angèle, Wanvoegbè Finagnon Armand, Agbodandé Kouessi Anthelme, Saïzonou Franck, Ahmed Adama, et al. Cardiac Diseases During Systemic Inflammatory Diseases in the Internal Medicine and Medical Oncology Department of NTHC-HKM of Cotonou. Am J Intern Med. 2021;9(6):257-261. doi: 10.11648/j.ajim.20210906.13

Copy | Download

@article{10.11648/j.ajim.20210906.13,
  author = {Azon Kouanou Angèle and Wanvoegbè Finagnon Armand and Agbodandé Kouessi Anthelme and Saïzonou Franck and Ahmed Adama and Alassani Adébayo and Dovonou Comlan Albert and Zannou Djimon Marcel and Houngbé Fabien},
  title = {Cardiac Diseases During Systemic Inflammatory Diseases in the Internal Medicine and Medical Oncology Department of NTHC-HKM of Cotonou},
  journal = {American Journal of Internal Medicine},
  volume = {9},
  number = {6},
  pages = {257-261},
  doi = {10.11648/j.ajim.20210906.13},
  url = {https://doi.org/10.11648/j.ajim.20210906.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajim.20210906.13},
  abstract = {Systemic inflammatory diseases are characterized by multivisceral involvement at some point in their evolution. This involvement can concern almost all organs, including the heart. Each systemic condition has a unique cardiac expression. The target of this study is to determine the frequency of cardiac involvement in systemic inflammatory diseases. This study is a cross-sectional, descriptive, and analytical study that was conducted within 07 months. The aim was to screen 23 patients followed for systemic inflammatory diseases for cardiac involvement. The mean age was 44 (±12) years old with a minimum of 24 and a maximum 64 years. Most of patients were women with a sex ratio (M/F) of 0.09. An echocardiographic abnormality was found in 26.1% of patients and 73.1% had an ECG abnormality. They included left atrial hypertrophy (43.4%), left ventricular hypertrophy (30.4%), right axial deviation (26.1%), low voltage (21.7%), right atrial hypertrophy (8.6%), S1Q3 appearance (8, 6%), pulmonary hypertension (8.6%), repolarization disorders (8.6%), sinus tachycardia (8.6%), middle tricuspid insufficiency (4.3%), middle pulmonary insufficiency (4.3%), and pericarditis (4.3%). Patients with systemic inflammatory diseases had cardiac disorders with rare clinical manifestations but with an incidental discovery either on ECG or on cardiac echodoppler. Hence, a systematic cardiac exploration in these patients was essential.},
 year = {2021}
}

Copy | Download